Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Buy
420,000
+45,000
+12% +$714K ﹤0.01% 1783
2026
Q1
$6.42M Sell
375,000
-6,300
-2% -$117K ﹤0.01% 1673
2025
Q4
$7.73M Buy
381,300
+281,300
+281% +$6.1M ﹤0.01% 1886
2025
Q3
$2.34M Buy
+100,000
New +$2.01M ﹤0.01% 2772
2025
Q2
Sell
-1,200,000
Closed -$24.9M 5587
2025
Q1
$24.9M Sell
1,200,000
-400,000
-25% -$7.2M 0.01% 919
2024
Q4
$18.9M Buy
+1,600,000
New +$19.8M 0.01% 1154
2024
Q3
Sell
-100,000
Closed -$733K 5512
2024
Q2
$733K Buy
+100,000
New +$789K ﹤0.01% 2792
2023
Q1
Sell
-260,100
Closed -$2.59M 5393
2022
Q4
$2.59M Buy
+260,100
New +$2.34M ﹤0.01% 2079

Other funds holding XPEV

Barclays's XPEV Position: Q2 2026 in Review

Barclays increased its XPeng (XPEV) stake by 374% in Q2 2026, buying an estimated $18.3M and bringing the position to 1,463,039 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1148.

Barclays first reported a position in XPEV in Q1 2022 and has held it in 18 quarters since. The position peaked at $30.6M in Q1 2022. 219 funds tracked by Wall St. Rank hold XPEV as of Q2 2026.

  • Barclays held 1,463,039 shares of XPeng worth $19.4M as of Q2 2026.
  • Barclays bought 1,154,152 XPeng shares in Q2 2026, an estimated $18.3M.
  • XPeng made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1148 holding.
  • Barclays first reported a position in XPeng in Q1 2022 and has held it in 18 quarters since.
  • Barclays's XPeng position peaked at $30.6M in Q1 2022.
  • 219 funds tracked by Wall St. Rank held XPeng as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.